Edition:
United States

Aralez Pharmaceuticals Inc (ARLZ.OQ)

ARLZ.OQ on NASDAQ Stock Exchange Global Select Market

0.29USD
13 Jul 2018
Change (% chg)

$0.01 (+3.57%)
Prev Close
$0.28
Open
$0.29
Day's High
$0.30
Day's Low
$0.28
Volume
111,718
Avg. Vol
198,022
52-wk High
$2.98
52-wk Low
$0.27

Chart for

About

Aralez Pharmaceuticals Inc. is a Canada-based specialty pharmaceutical company. The Company focuses on acquiring, developing and commercializing products in cardiovascular, pain and other areas. The Company's products include Fibricor, Cambia, Fiorinal, Fiorinal C, Soriatane, Bezalip SR, NeoVisc, Uracyst, Durela, Proferrin,... (more)

Overall

Beta: --
Market Cap(Mil.): $19.53
Shares Outstanding(Mil.): 67.19
Dividend: --
Yield (%): --

Financials

  ARLZ.OQ Industry Sector
P/E (TTM): -- 29.26 33.20
EPS (TTM): -1.76 -- --
ROI: -29.14 13.66 13.23
ROE: -262.08 15.51 15.28

BRIEF-Aralez Pharmaceuticals Announces Discontinuation Of U.S. Commercial Operations, With Reductions In Operating Expenses

* ARALEZ PHARMACEUTICALS INC - DISCONTINUATION OF U.S. COMMERCIAL OPERATIONS, WITH SIGNIFICANT REDUCTIONS IN OPERATING EXPENSES

May 08 2018

BRIEF-Aralez Pharmaceuticals Reports Q1 Loss Per Share Of $0.29

* 1Q 2018 NET REVENUES INCREASED TO $38.1 MILLION VERSUS $26.0 MILLION IN 1Q 2017

May 08 2018

BRIEF-Aralez Pharmaceuticals Says Unit Entered Into Modification Of Contract

* ARALEZ PHARMA - UNIT ENTERED INTO MODIFICATION OF CONTRACT PURSUANT TO WHICH U.S. EXERCISED SECOND RENEWAL OPTION UNDER THAT VA NATIONAL CONTRACT

Apr 05 2018

BRIEF-Aralez Pharmaceuticals Inc - ‍On March 13, Board Appointed Michael Kaseta As Company's CFO - SEC Filing

* ARALEZ PHARMACEUTICALS INC - ‍ON MARCH 13, BOARD APPOINTED MICHAEL KASETA AS COMPANY'S CFO - SEC FILING Source text (http://bit.ly/2p8Z0x1) Further company coverage: (Reuters.Brief@thomsonreuters.com)

Mar 14 2018

BRIEF-Aralez Pharmaceuticals Posts Q4 Loss Per Share $0.68‍‍​

* ARALEZ ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2017 FINANCIAL RESULTS

Mar 13 2018

Earnings vs. Estimates